Label (Label)
Lescol Tablet, Extended Release
Product Images NDC 66758-211
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lescol (NDC 66758-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fluvastatin Sodium Structural Formula (Lescol 02)
Lescol-03 (Lescol 03)
Lescol-04 (Lescol 04)
This text provides a detailed comparison of the incidence of cardiac events between the use of Lescol and a placebo on a group of 844 and 833 participants, respectively. The table includes information on primary endpoints such as recurrent cardiac events, cardiac death, nonfatal myocardial infarction, and revascularization, as well as secondary endpoints like late revascularization. Additionally, it presents risk reductions percentages and Cox Risk Ratios calculations. Note that revascularization procedures of the target lesion were excluded within the first 6 months of the initial procedure for the Cox Risk Ratio.*
Lescol-05 (Lescol 05)
This text provides data on the change in minimum lumen diameter (mm) for patients undergoing monotherapy with Lescol or placebo as well as combination therapy. The study includes a sample size for each group and indicates the addition of cholestyramine therapy (CME).*
Lescol-06 (Lescol 06)
The provided text appears to be showing statistical data related to the effectiveness of a certain treatment (Lescol) in reducing the diameter stenosis percentage compared to a placebo and in combination with cholestyramine therapy. It includes different percentages and sample sizes for each group. The text also mentions categories such as Monotherapy, All Patients, and Combination therapy.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
